LYCOS INC
424B3, 1999-03-02
ADVERTISING
Previous: LOU HOLLAND TRUST, 485APOS, 1999-03-02
Next: PRUDENTIAL VARIABLE CONTRACT ACCOUNT GI-2, 485APOS, 1999-03-02




                                   FILED PURSUANT TO RULE 424(b)(3) AND (c)
                                                      FILE NUMBER 333-61413


      THIRTEENTH PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED AUGUST 24, 1998

                                4,185,124 SHARES

                                   LYCOS, INC.

                                  COMMON STOCK



This Thirteenth Prospectus Supplement (the "Thirteenth  Prospectus  Supplement")
supplements  the  Prospectus  dated  August  24,  1998 (the  "Prospectus"),  the
Prospectus   Supplement   dated  September  15,  1998  (the  "First   Prospectus
Supplement"),  the Second  Prospectus  Supplement  dated  October  28, 1998 (the
"Second Prospectus Supplement"),  the Third Prospectus Supplement dated November
12, 1998 (the "Third Prospectus  Supplement"),  the Fourth Prospectus Supplement
dated  November  18,  1998  (the  "Fourth  Prospectus  Supplement"),  the  Fifth
Prospectus   Supplement   dated   November  19,  1998  (the  "Fifth   Prospectus
Supplement"), the Sixth Prospectus Supplement dated December 1, 1998 (the "Sixth
Prospectus  Supplement"),  the Seventh  Prospectus  Supplement dated December 2,
1998 (the "Seventh  Prospectus  Supplement"),  the Eighth Prospectus  Supplement
dated  December  4,  1998  (the  "Eighth  Prospectus  Supplement"),   the  Ninth
Supplement  dated  December 21, 1998 (the "Ninth  Prospectus  Supplement"),  the
Tenth  Prospectus  Supplement  dated  December  28, 1998 (the "Tenth  Prospectus
Supplement"),  the Eleventh  Prospectus  Supplement  dated January 14, 1999 (the
"Eleventh  Prospectus") and the Twelfth Prospectus Supplement dated February 12,
1999 (the  "Twelfth  Prospectus  Supplement")  of Lycos,  Inc.  ("Lycos"  or the
"Company") relating to the public offering, which is not being underwritten, and
sale of up to 4,185,124  shares of Common Stock,  par value $0.01 per share (the
"Shares")  of the  Company,  which may be offered  and sold from time to time by
certain stockholders of the Company or by pledgees, donees, transferees or other
successors  in  interest  that  receive  such  shares  as  a  gift,  partnership
distribution or other non-sale  related  transfer (the "Selling  Stockholders").
The Company will receive no part of the proceeds of such sales.  The Shares were
originally issued or reserved for issuance by the Company in connection with the
Company's  acquisition  of  WhoWhere?  Inc., a  California  corporation,  by and
through a merger of a wholly-owned  subsidiary of Lycos, What Acquisition Corp.,
with and into WhoWhere?  Inc. (the  "Acquisition").  The "Selling  Stockholders"
Section  of  the  Prospectus,   the  First  Prospectus  Supplement,  the  Second
Prospectus Supplement,  the Third Prospectus  Supplement,  the Fourth Prospectus
Supplement,  the Fifth Prospectus  Supplement,  the Sixth Prospectus Supplement,
the Seventh Prospectus Supplement,  the Eighth Prospectus Supplement,  the Ninth
Prospectus Supplement,  the Tenth Prospectus Supplement, the Eleventh Prospectus
Supplement  and the Twelfth  Prospectus  Supplement are hereby  supplemented  to
reflect the gift made by Edward  Shelton to Tamara Sophia  Shelton in the amount
of 4,880 shares after the date of the Prospectus, the First Prospectus


<PAGE>



Supplement,  the Second Prospectus Supplement,  the Third Prospectus Supplement,
the Fourth Prospectus  Supplement,  the Fifth Prospectus  Supplement,  the Sixth
Prospectus Supplement,  the Seventh Prospectus Supplement, the Eighth Prospectus
Supplement,  the Ninth Prospectus  Supplement,  the Tenth Prospectus Supplement,
the Eleventh Prospectus Supplement and the Twelfth Prospectus  Supplement.  This
Thirteenth  Prospectus  Supplement  should  be  read  in  conjunction  with  the
Prospectus,  the First Prospectus Supplement,  the Second Prospectus Supplement,
the Third Prospectus  Supplement,  the Fourth Prospectus  Supplement,  the Fifth
Prospectus Supplement,  the Sixth Prospectus Supplement,  the Seventh Prospectus
Supplement,  the Eighth Prospectus Supplement,  the Ninth Prospectus Supplement,
the Tenth  Prospectus  Supplement,  the Eleventh  Prospectus  Supplement and the
Twelfth Prospectus Supplement,  and is qualified by reference to the Prospectus,
the First Prospectus  Supplement,  the Second Prospectus  Supplement,  the Third
Prospectus Supplement,  the Fourth Prospectus  Supplement,  the Fifth Prospectus
Supplement,  the Sixth Prospectus Supplement, the Seventh Prospectus Supplement,
the Eighth Prospectus  Supplement,  the Ninth Prospectus  Supplement,  the Tenth
Prospectus  Supplement,  the  Eleventh  Prospectus  Supplement  and the  Twelfth
Prospectus  Supplement,  except  to  the  extent  that  the  information  herein
contained  supersedes the  information  contained in the  Prospectus,  the First
Prospectus Supplement,  the Second Prospectus  Supplement,  the Third Prospectus
Supplement,  the Fourth Prospectus Supplement,  the Fifth Prospectus Supplement,
the Sixth Prospectus Supplement,  the Seventh Prospectus Supplement,  the Eighth
Prospectus  Supplement,  the Ninth Prospectus  Supplement,  the Tenth Prospectus
Supplement,  the  Eleventh  Prospectus  Supplement  and the Twelfth  Prospectus.
Capitalized  terms  used  in  this  Thirteenth  Prospectus  Supplement  and  not
otherwise defined herein have the meanings specified in the Prospectus.




<PAGE>


       THE DATE OF THIS THIRTEENTH PROSPECTUS SUPPLEMENT IS MARCH 2, 1999

                              SELLING STOCKHOLDERS

         On February 4, 1999,  four thousand eight hundred eighty (4,880) of the
Shares  beneficially owned by Edward Shelton reflected in the Prospectus and the
supplements  thereto were gifted to Tamara Sophia Shelton.  The table of Selling
Stockholders in the Prospectus and the supplements thereto are hereby amended to
reflect such gift and  supplemented to  specifically  include Shares received in
such gift.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission